|
|
3077 Teagarden Street
San Leandro, CA 94577 USA
phone:(510) 614-4550
fax:(510) 667-0435
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.endobionics.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Drug-device systems for local treatment of tumors and vascular, cardiac, and neurological diseases. |
|
| Management |
| Thomas M. Loarie, Chairman and Chief Executive Officer; Kirk Seward, Ph.D., Co-Founder, Director, President, Chief Technology Officer; Wendy Hitchcock, Chief Business Officer, Executive Vice President, Finance and Corporate Development; Sid Gandionco, Vice President, Engineering |
| |
|
|
| |
|
| Keywords |
| vascular, cardiac, neurology |
|
|
|
| Description |
|
EndoBionics, Inc. is developing cost-effective, innovative drug-device systems for local treatment of tumors and vascular, cardiac, and neurological diseases. |
|
| Technology / Differentiation |
| EndoBionics, founded in 2000, has created the first micro medical device to inject safely through vessel walls. The 510(k)-cleared Syringe (MicroSyringe) is a wire-guided needle injection catheter that is threaded through the blood vessels to the deep tissues of the body, including the heart and other major organs. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members